Pirlimycin for Ox: Mastitis Treatment, Dosing & Side Effects

This information is for educational purposes only. Never give your pet any medication without your veterinarian's guidance. Dosing, frequency, and safety depend on your pet's specific health profile.

Pirlimycin is a prescription lincosamide antibiotic used in food-producing cattle as an intramammary infusion. In the U.S., the labeled product is Pirsue, and each 10 mL syringe contains 50 mg pirlimycin free-base equivalent for infusion directly into an affected udder quarter. It is not an oral medication and it is not a routine injectable drug for general infections.

Pirlimycin works by inhibiting bacterial protein synthesis at the 50S ribosomal subunit. That makes it most useful against certain gram-positive mastitis pathogens, especially Staphylococcus aureus, Streptococcus agalactiae, Streptococcus dysgalactiae, and Streptococcus uberis. Because it is placed in the udder, it is designed for mastitis treatment rather than whole-body therapy.

For pet parents caring for an ox or dairy bovine, the most important point is that pirlimycin is a labeled mastitis drug for lactating dairy cattle, and food-safety rules matter. Milk and meat withdrawal times depend on how long treatment continues, so your vet should guide the exact plan and recordkeeping.

Pirlimycin is used for clinical and subclinical mastitis in lactating dairy cattle when the infection is associated with susceptible Staphylococcus and Streptococcus species. In practical terms, your vet may consider it when there are visible milk changes, udder inflammation, elevated somatic cell counts, or culture results that fit the labeled organisms.

It is often most useful in cases where a gram-positive mastitis pathogen is suspected or confirmed. That matters because mastitis is not one disease with one cause. Some cases are caused by environmental gram-negative bacteria or mixed infections, and those cases may need a different plan, supportive care, or a different antimicrobial choice.

Pirlimycin is not a catch-all mastitis treatment. Chronic infections, severe tissue damage, fibrosis, or microabscesses can reduce how well intramammary drugs spread through the gland. Your vet may recommend milk culture, somatic cell count review, anti-inflammatory support, or a broader herd-level mastitis plan alongside treatment.

The labeled dose for pirlimycin in lactating dairy cattle is one full 10 mL syringe infused into each affected quarter, then repeat in 24 hours. If needed, treatment may continue once daily at 24-hour intervals for up to 8 consecutive days under the product label. Good teat-end preparation and clean infusion technique are essential before every treatment.

In plain language, this is a quarter-based dose, not a body-weight dose. The medication is placed directly into the infected quarter after the udder is milked out and the teat end is cleaned with a separate alcohol pad for each teat. Your vet may adjust the overall treatment plan based on culture results, severity, number of quarters involved, milk production status, and herd protocols.

Food-safety timing is critical. Milk must be discarded during treatment and for 36 hours after the last treatment. For meat withdrawal, the labeled interval is 9 days after the standard 2-dose regimen and 21 days after extended therapy longer than 2 days, up to 8 days. Because residue violations can happen if the drug is used outside label directions, your vet should confirm the exact withdrawal schedule for your animal.

Pirlimycin is generally well tolerated when used correctly, but side effects can happen. The most important reported problems are increased somatic cell counts, worsening mastitis signs, udder swelling, and abnormal milk, especially with repeated infusions. Extended therapy can increase the risk of new intramammary infection from environmental bacteria, including gram-negative coliform organisms, if infusion technique is not meticulous.

That means the medication itself is only part of the story. If the teat end is not cleaned thoroughly, bacteria can be introduced during treatment. In severe cases reported with extended therapy, cows developed significant clinical mastitis and some died from coliform mastitis. If milk looks more abnormal, the quarter becomes hotter or more swollen, appetite drops, or the animal seems systemically ill, see your vet immediately.

People handling pirlimycin should also use care. Product safety information notes that it may cause skin or eye irritation, and people sensitive to this drug class may develop allergic reactions. Wearing gloves and following clean handling steps is a smart part of treatment.

There are no widely emphasized label-listed drug interactions for intramammary pirlimycin in cattle, but that does not mean interactions are impossible. As a lincosamide, pirlimycin shares ribosomal binding characteristics with macrolides, streptogramins, and phenicols, so your vet may think carefully before combining it with other antimicrobials that act at similar sites.

The bigger real-world concern is usually treatment overlap and residue management rather than a classic drug-drug interaction. If an ox is also receiving another mastitis tube, a systemic antibiotic, anti-inflammatory medication, or extra-label therapy, your vet needs the full list to avoid conflicting withdrawal times and to make sure the treatment plan still fits food-animal regulations.

You can help by telling your vet about every product being used, including intramammary tubes, injectable antibiotics, NSAIDs, teat sealants, supplements, and any recent treatments from herd protocols. In food animals, even a reasonable medication combination can create residue or compliance problems if it is not coordinated carefully.